Emergent

General Information

Identification Code: 946394317378-56

Website: http://emergentbiosolutions.com/

Entity Form: Inc.

Registration Category: Companies & groups

Registration Date: 5/15/2015

Last Update: 9/5/2023

Mission & Interests

Goals: With over 20 years of experience working with governments, intergovernmental organizations, first responders, and NGOs across the globe, Emergent BioSolutions seeks to be a partner in strategic preparedness against natural, accidental, and man-made public health threats. Emergent BioSolutions develops, manufactures, and delivers protections against public health threats through a pipeline of innovative vaccines and therapeutics.

Interests Represented: Promotes their own interests or the collective interests of their members

Interests:

Borders and security
External relations
Foreign affairs and security policy
Humanitarian aid and civil protection
Institutional affairs
Public health
Research and innovation

Levels of Interest:

national
global
european

Activities

Main EU Legislative Proposals: Emergent BioSolutions engages in dialogues with EU institutions on public health including EU4Health, cross-border health threats including COVID-19, and HERA and EU FAB, security, medicinal products for human use, internal security, civil protection, and crisis management including rescEU/UCPM, counterterrorism, EU CBRN Action Plan.

Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: 1455, Pennsylvania Avenue, N.W.The Willard, Suite 1225

Post Code: 20004

City: Washington D.C.

Country: UNITED STATES

Phone:

Indic Phone: 1

Phone Number: 2406313398

EU Office

Address: 1455, Pennsylvania Avenue, N.W.The Willard, Suite 1225

Post Code: 20004

City: Washington D.C.

Country: UNITED STATES

Phone:

Indic Phone: 1

Phone Number: 2406313398

Financial Data

Closed Year:

Start Date:

End Date:

Funding Sources:

Contributions:

Total Budget: 0

Grants:

Current Year:

Grants:

Complementary Information: Emergent is registered in the German Lobbyregister and the French Haute Autorité pour la transparence de la vie publique.

Membership Information

Members10 Percent: 2

Members25 Percent: 7

Members50 Percent: 1

Members: 10

Members F T E: 2.450000047683716

Info Members: Number of persons involved in activities covered by the register both in-house and externally is 11. This includes Mr Chris Frech, Senior Vice President Government Affairs – person in charge of EU relations and Mr Ask Eirik Storsve, Head of European Government Affairs (50% of work time). Emergent BioSolutions works with 9 more consultants, devoting 25% or 10% of working time: Peter Tulkens, FIPRA (25%) Francisco Ferrera, FIPRA (25%) Aymeric Boillot, FIPRA (25%) Julie Steenlant, FIPRA (25%) Marc Piper, EUK Consulting (25%) Eirini Kallinikou, EUK Consulting (25%) Jon Hall, Resilience Advisors (25%) Marie Eliane Walters, Erstelesung (10%) Anna Ehleringer, Erstelesung (10%)